Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 389

Related Articles by Review for PubMed (Select 17927296)

1.

Adverse effects of atypical antipsychotics : differential risk and clinical implications.

Haddad PM, Sharma SG.

CNS Drugs. 2007;21(11):911-36. Review.

PMID:
17927296
2.
3.

Antipsychotic-induced hyperprolactinaemia: mechanisms, clinical features and management.

Haddad PM, Wieck A.

Drugs. 2004;64(20):2291-314. Review.

PMID:
15456328
4.

Ziprasidone: an atypical antipsychotic drug for the treatment of schizophrenia.

Stimmel GL, Gutierrez MA, Lee V.

Clin Ther. 2002 Jan;24(1):21-37. Review.

PMID:
11833834
5.

Drug Class Review: Atypical Antipsychotic Drugs: Final Update 3 Report [Internet].

McDonagh M, Peterson K, Carson S, Fu R, Thakurta S.

Portland (OR): Oregon Health & Science University; 2010 Jul.

6.

Novel antipsychotics, extrapyramidal side effects and tardive dyskinesia.

Barnes TR, McPhillips MA.

Int Clin Psychopharmacol. 1998 Mar;13 Suppl 3:S49-57. Review.

PMID:
9690971
7.

Adverse effects of the atypical antipsychotics. Collaborative Working Group on Clinical Trial Evaluations.

[No authors listed]

J Clin Psychiatry. 1998;59 Suppl 12:17-22. Review.

PMID:
9766615
8.

Tolerability profile of atypical antipsychotics in children and adolescents.

Stigler KA, Potenza MN, McDougle CJ.

Paediatr Drugs. 2001;3(12):927-42. Review.

PMID:
11772153
9.
10.

Impact of atypical antipsychotics on quality of life in patients with schizophrenia.

Awad AG, Voruganti LN.

CNS Drugs. 2004;18(13):877-93. Review.

PMID:
15521791
11.

Adverse effects of antipsychotic agents. Do newer agents offer advantages?

Owens DG.

Drugs. 1996 Jun;51(6):895-930. Review.

PMID:
8736614
12.

[Leponex, 10 years after -- a clinical review].

Llorca PM, Pere JJ.

Encephale. 2004 Sep-Oct;30(5):474-91. Review. French.

PMID:
15627052
13.

Adverse effects of atypical antipsychotics in the elderly: a review.

Gareri P, De Fazio P, De Fazio S, Marigliano N, Ferreri Ibbadu G, De Sarro G.

Drugs Aging. 2006;23(12):937-56. Review.

PMID:
17154659
14.

Ziprasidone: the fifth atypical antipsychotic.

Caley CF, Cooper CK.

Ann Pharmacother. 2002 May;36(5):839-51. Review.

PMID:
11978164
15.

A review of atypical antipsychotic drugs versus conventional medication in schizophrenia.

Luft B, Taylor D.

Expert Opin Pharmacother. 2006 Sep;7(13):1739-48. Review.

PMID:
16925501
16.

The SOHO (Schizophrenia Outpatient Health Outcome) study: implications for the treatment of schizophrenia.

Haro JM, Salvador-Carulla L.

CNS Drugs. 2006;20(4):293-301. Review.

PMID:
16599647
17.
18.

Effects of newer antipsychotics on extrapyramidal function.

Tarsy D, Baldessarini RJ, Tarazi FI.

CNS Drugs. 2002;16(1):23-45. Review. Erratum in: CNS Drugs. 2003;17(3):202.

PMID:
11772117
19.

A review of the effect of atypical antipsychotics on weight.

Nasrallah H.

Psychoneuroendocrinology. 2003 Jan;28 Suppl 1:83-96. Review.

PMID:
12504074
20.

Atypical antipsychotics: Part II: Adverse effects, drug interactions, and costs.

Brown CS, Markowitz JS, Moore TR, Parker NG.

Ann Pharmacother. 1999 Feb;33(2):210-7. Review.

PMID:
10084417
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk